Mitochondria

Urolithin A

Lifespan / validated healthspanEvidence level E

Level E marks a central question without dependable direct human evidence; read the outcome conclusion rather than treating the letter as a direction of effect.

This E grade answers the central longevity question only. Other outcomes are graded separately below.

IN PLAIN LANGUAGE

Why people are interested

A gut-derived molecule studied around mitochondrial quality control. One direct formulation clearly raised measured exposure, but walking, muscle and biomarker results remain mixed or exploratory, and no human trial shows longer lifespan or validated healthspan.

Outcome map

One ingredient. Different questions.

Evidence can be stronger for a specific marker or population and weaker for a broader promise. Each row answers a separate question.

01
Human lifespan or validated healthspan
No completed human intervention reviewed demonstrated longer lifespan or an improvement in a validated healthspan endpoint.
Evidence level E
02
Circulating exposure
One exact high-purity direct formulation produced greater measured metabolite exposure than one tested juice challenge; exposure is not efficacy.
Evidence level B
03
Six-minute walk distance
The corrected two-trial estimate favored Urolithin A but its confidence interval crossed zero, leaving the result statistically inconclusive and low certainty.
Evidence level C
04
Peak power and ATP production
The named primary outcomes did not significantly improve in their exact trial contexts, which blocks a broad energy or power benefit claim.
Evidence level B
05
Torque or contraction endurance
Selected exploratory secondary signals exist, but small studies, null primary outcomes and multiplicity limits prevent a firm benefit conclusion.
Evidence level C
06
Short-term tolerability
Selected short trials did not show a consistent serious treatment-related pattern under their exact conditions; universal or long-term safety is not established.
Evidence level B

Library trackResearch Radar

Last reviewed22 Aug 2026

Guide scopeIngredient research only

How it may work

A gut-microbial metabolite studied in mitochondrial quality-control biology. Measured circulating metabolites and mechanistic biomarkers do not establish mitophagy benefit, age reversal or a clinical outcome.

What people have studied

One exact high-purity direct-Urolithin-A formulation produced greater circulating conjugated-metabolite exposure than one tested pomegranate-juice challenge, but exposure is not efficacy. The corrected two-trial six-minute-walk synthesis was statistically inconclusive and low certainty; exploratory muscle, recovery and immune-cell signals coexist with null primary and other outcomes. No completed human intervention demonstrates longer lifespan or validated healthspan.

What to consider

Selected direct-Urolithin-A trials did not show a consistent serious treatment-related pattern over their short study periods. That does not establish long-term, rare-event, interaction, pregnancy, pediatric or medically complex safety, or transfer to another source or finished product.

Local pathway

This science review does not establish a Thailand market route. Ingredient source, formulation and finished-product status require separate official confirmation.

Sources + indexes

See where the explanation comes from.

Open the linked research and official records behind this guide. Early topics may begin with a research index while stronger sources are added.